Evidence map›Paper›PMID 19497859›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Gamma-actin is required for cytoskeletal maintenance but not development.

Inna A Belyantseva, Benjamin J Perrin, Kevin J Sonnemann, Mei Zhu, Ruben Stepanyan, JoAnn McGee, Gregory I Frolenkov, Edward J Walsh, Karen H Friderici, Thomas B Friedman and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 181 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Cochlear Implantation Outcomes in Genotyped Subjects with Sensorineural Hearing Loss.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Exposure ofFrontiers in veterinary science · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Inna A BelyantsevaLaboratory of Molecular Genetics, National Institute on Deafness and Other Communication Disorders/National Institutes of Health, Rockville, MD 20850, USA.
Benjamin J Perrin
Kevin J Sonnemann
Mei Zhu
Ruben Stepanyan
JoAnn McGee
Gregory I Frolenkov
Edward J Walsh
Karen H Friderici
Thomas B Friedman
James M Ervasti
University of Minnesota · USBoys Town National Research Hospital · USMichigan State University · USNational Institute on Deafness and Other Communication Disorders · USNational Institutes of Health · USUniversity of Kentucky · US

Funding

Identification of Genes Causing Syndromic And Nonsyndromic Hearing ImpairmentZIADC000039 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI FRIEDMAN, THOMAS · 2009 to 2025
$48.7M
Costamere Defects in Muscular DystrophiesR01AR049899 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI ERVASTI, JAMES M · 2005 to 2025
$8.2M
Training Grant: Functional Proteomics of AgingT32AG029796 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, Douglas G Mashek · 2008 to 2026
$6.6M
Molecular Analysis Of Human Hereditary DeafnessZ01DC000060 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI GRIFFITH, ANDREW J · 2001 to 2008
$3.0M
Autosomal Dominant Hearing LossR01DC004568 · NIDCD · MICHIGAN STATE UNIVERSITY · PI FRIDERICI, KAREN H. · 2001 to 2009
$2.4M
Myosin XVA and Other Genes Essential for Stereocilia MorphogenesisZ01DC000048 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI FRIEDMAN, THOMAS BAER · 1998 to 2008
$1.7M
Role of Cytoplasmic Actin Isoforms in the Inner EarF32DC009539 · NIDCD · UNIVERSITY OF MINNESOTA · PI PERRIN, BENJAMIN J · 2008 to 2010
$160k
Intramural NIH HHS Z01 DC000048Intramural NIH HHS Z01 DC000060NIAMS NIH HHS R01 AR049899NIA NIH HHS T32 AG029796NIDCD NIH HHS DC004568NIDCD NIH HHS F32 DC009539NIDCD NIH HHS R01 DC004568
6 · The paper itself

Abstract

Beta(cyto)-actin and gamma(cyto)-actin are ubiquitous proteins thought to be essential building blocks of the cytoskeleton in all non-muscle cells. Despite this widely held supposition, we show that gamma(cyto)-actin null mice (Actg1(-/-)) are viable. However, they suffer increased mortality and show progressive hearing loss during adulthood despite compensatory up-regulation of beta(cyto)-actin. The surprising viability and normal hearing of young Actg1(-/-) mice means that beta(cyto)-actin can likely build all essential non-muscle actin-based cytoskeletal structures including mechanosensory stereocilia of hair cells that are necessary for hearing. Although gamma(cyto)-actin-deficient stereocilia form normally, we found that they cannot maintain the integrity of the stereocilia actin core. In the wild-type, gamma(cyto)-actin localizes along the length of stereocilia but re-distributes to sites of F-actin core disruptions resulting from animal exposure to damaging noise. In Actg1(-/-) stereocilia similar disruptions are observed even without noise exposure. We conclude that gamma(cyto)-actin is required for reinforcement and long-term stability of F-actin-based structures but is not an essential building block of the developing cytoskeleton.

Indexed as

ActinsAnimalsCytoskeletonHearing LossMiceMice, KnockoutMicroscopy, Electron, ScanningMicroscopy, FluorescenceActins

Identifiers

PMID19497859
PMCPMC2701000
OpenAlexW2161239003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.